Great @Quiltman with some maths wizardry we can might actually be able to calculate a reasonable estimate for ALSFRS-R reduction rate from the info released. We have the PROACT database reference and decline and survival. To the extent progression rates correlate to survival perhaps can get a reasonable estimate. I will do some number crunching.
Ann: FDA Provides Clear Feedback for ODD Approval, page-262
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $92.46M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.0¢ | $45.80K | 239.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 103675 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 146686 | 7 |
View Market Depth
| Last trade - 11.34am 04/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |